NCT01678872Active, not recruitingPhase 1
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to examine the long term safety of an experimental gene transfer agent, RetinoStat®, designed to treat neovascular age-related macular degeneration.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- First submitted
- 31 Aug 2012
- Start date
- Aug 2012
- Primary completion date
- Mar 2029
- Lead sponsor
- Oxford BioMedica
- Diseases
- Macular degeneration
- NCT number
- NCT01678872
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 18
- From Aug 2012 to the primary completion date, Mar 2029
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Did not receive RetinoStat® as part of the RS1/001/10 protocol
Who the study is looking for
- Must have received a subretinal injection of RetinoStat
- Must have been enrolled in Protocol RS1/001/10
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| John Hopkins University Hospital Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| University of Iowa Hospitals & Clinics Coordinator of this site? Confirm its status | Iowa City | United States | Unknown status |
| Oregon Health Science University Coordinator of this site? Confirm its status | Portland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.